- Report
- November 2025
- 110 Pages
North America
From €2988EUR$3,250USD£2,540GBP
- Report
- November 2025
- 140 Pages
Europe
From €2988EUR$3,250USD£2,540GBP
- Report
- October 2025
- 90 Pages
North America
From €2988EUR$3,250USD£2,540GBP
- Report
- February 2026
- 109 Pages
North America
From €5511EUR$5,995USD£4,685GBP
- Report
- February 2026
- 117 Pages
Europe
From €5511EUR$5,995USD£4,685GBP
- Report
- February 2026
- 117 Pages
Asia Pacific
From €5511EUR$5,995USD£4,685GBP
- Report
- January 2026
- 79 Pages
Middle East, Africa
From €3171EUR$3,450USD£2,696GBP
- Report
- January 2026
- 92 Pages
Asia Pacific
From €3631EUR$3,950USD£3,087GBP
- Report
- January 2026
- 96 Pages
Europe
From €3631EUR$3,950USD£3,087GBP
- Report
- January 2026
- 86 Pages
North America
From €3171EUR$3,450USD£2,696GBP
- Report
- October 2025
- 84 Pages
Middle East
From €4137EUR$4,500USD£3,517GBP
- Report
- November 2023
- 127 Pages
Global
From €4137EUR$4,500USD£3,517GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3309EUR$3,600USD£2,814GBP
- Report
- August 2025
- 154 Pages
Global
From €2436EUR$2,650USD£2,071GBP
- Report
- June 2025
- 379 Pages
Global
From €4550EUR$4,950USD£3,869GBP
- Report
- January 2023
- 127 Pages
Global
From €2068EUR$2,250USD£1,758GBP
- Report
- April 2021
Global
From €827EUR$900USD£703GBP
- Report
- June 2025
- 151 Pages
Global
From €3217EUR$3,500USD£2,735GBP
- Report
- March 2022
- 260 Pages
Global
From €3447EUR$3,750USD£2,931GBP
- Report
- February 2024
- 78 Pages
Global
From €2712EUR$2,950USD£2,306GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more